Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions

Thursday, October 31, 2013
This study demonstrates for the first time a selective vascular disrupting effect of CA4P on endometriotic lesions, indicating that vascular disrupting agents may be suitable for the therapy of endometriosis.

Read More

Translate »